Xiaosong Chen
11PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 13, 2026
Decoding adipocyte heterogeneity through single-nucleus transcriptomics unveils subtype-specific adipocytes orchestrate immunosuppressive niches in breast cancer.Yiwei Tong, Zheng Wang, Niu Qiao
|Dec 09, 2025
Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial.Xiaosong Chen, Jiahui Huang, Haoting Shi
|Jul 14, 2025
Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer.Cuiyan Yang, Haoyu Wang, Yiwei Tong
|Aug 21, 2023
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases.Siji Zhu, Yujie Lu, Xiaochun Fei
|Jun 27, 2023
Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.Yujie Lu, Yiwei Tong, Xiaochun Fei
|May 09, 2023
Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.Shuning Ding, Niu Qiao, Qingchen Zhu
Pageof 2
